1-3 of 3
Esperanza Lavilla
Close
Sort by
Journal Articles

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

Cristina Pascual Izquierdo, María Eva Mingot-Castellano, Ana E. Kerguelen Fuentes, José García-Arroba Peinado, Joan Cid, Maria Moraima Jimenez, David Valcarcel, Inés Gómez-Seguí, Javier de la Rubia, Paz Martin, Rosa Goterris, Luis Hernández, Inmaculada Tallón, Sara Varea, Marta Fernández, Nadia García-Muñoz, Míriam Vara, Miguel Fernández Zarzoso, Faustino García-Candel, María Liz Paciello, Irene García-García, Saioa Zalba, Verónica Campuzano, José María Gala, Julia Vidán Estévez, Gemma Moreno Jiménez, José Luis López Lorenzo, Elena González Arias, Carmen Freiría, María Solé, Laura Francisca Ávila Idrovo, José Carlos Hernández Castellet, Naylen Cruz, Esperanza Lavilla, Albert Pérez-Montaña, Jon Ander Atucha, María Esperanza Moreno Beltrán, Juán Ramón Moreno Macías, Ramón Salinas, Julio del Rio-Garma
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6219–6227.
https://doi.org/10.1182/bloodadvances.2022008028
Published: 2022
Includes: Supplemental data
Journal Articles

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

Clinical Trials & Observations
David Martínez-Cuadrón, Juan E. Megías-Vericat, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Cristina Gil, Eliana Aguiar, Juan Bergua, José L. López-Lorenzo, Teresa Bernal, Ana Espadana, Mercedes Colorado, Carlos Rodríguez-Medina, María López-Pavía, Mar Tormo, Lorenzo Algarra, María-Luz Amigo, María J. Sayas, Jorge Labrador, Juan I. Rodríguez-Gutiérrez, Celina Benavente, Lissette Costilla-Barriga, Raimundo García-Boyero, Esperanza Lavilla-Rubira, Susana Vives, Pilar Herrera, Daniel García-Belmonte, María Mar Herráez, Graça Vasconcelos Esteves, Maria I. Gómez-Roncero, Ana Cabello, Guiomar Bautista, Amaia Balerdi, José Mariz, Blanca Boluda, Miguel Á. Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1278–1295.
https://doi.org/10.1182/bloodadvances.2021005335
Published: 2022
Includes: Supplemental data
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data